Pharma Cleanroom HVAC — ISO 14644 + WHO TRS 1019 + Schedule M 2023 + USFDA 21 CFR 211
A 1500 m² Indian OSD generics plant typically runs Grade D weighing + Grade C granulation/compression/coating + Grade A LAF sampling = 80 TR chilled water + 38 % AHU diversity. ISO 14644-1 + WHO TRS 1019 + Schedule M 2023 (revised Dec 2023) + USFDA 21 CFR Part 211 + EU GMP Annex 1:2022 set the framework. Three failures the Schedule M revision now flags: recovery-time not demonstrated under operational disturbance, solvent-handling exhaust on mild-steel duct (needs SS + Class 1 Div 2 per IS/IEC 60079), HEPA integrity testing annually instead of 6-monthly for Grade C/D sterile-adjacent rooms.
Pharma cleanroom classification framework
Indian pharma manufacturing follows three overlapping standards — ISO 14644-1 (international), WHO TRS 1019 Annex 2 (sterile products GMP), and Schedule M (Indian Drugs + Cosmetics Rules, revised 2023). The classes Grade A/B/C/D map to ISO classes 5/5(at rest)/7/8 with different at-rest vs operational requirements. A 1500 m² oral solid dosage (OSD) facility for a Tier-2 Indian generics manufacturer typically has Grade D weighing + Grade C compression + Grade D packing, with Grade A LAF only at sampling.
Cleanroom HVAC design — 1500 m² OSD pharma facility
| Area | Grade | ISO class (operational) | ACH | ΔP (Pa) vs corridor | Recovery (≤ class in 15-20 min) | Filter |
|---|---|---|---|---|---|---|
| Weighing booth | D | ISO 8 op / 7 rest | 20-30 | +15 | yes | H13 HEPA |
| Dispensing | D | ISO 8 | 20-30 | +15 | yes | H13 |
| Granulation | C | ISO 7 op / ISO 6 rest | 30-40 | +15 | yes | H14 HEPA |
| Compression | C | ISO 7 | 30-40 | +15 | yes | H14 |
| Coating | C | ISO 7 | 40 | +15 | yes | H14 + solvent recovery |
| Packing primary | D | ISO 8 | 15-25 | +15 | yes | H13 |
| Packing secondary | none | — | 10 | +10 | — | F9 bag |
| QC sampling LAF | A in B | ISO 5 | 480 (laminar) | +15 (vs B) | — | H14 + ULPA |
| Microbiology | C | ISO 7 | 30-40 | +15 | yes | H14 |
| Solvent storage | — | — | 12 ACH (NBC Pt 4) | -25 | — | — |
Three Indian pharma cleanroom failures Schedule M 2023 will flag
- Recovery time not demonstrated — Schedule M 2023 + WHO TRS 1019 require recovery to specified class within 15-20 min after particle disturbance. Most Indian facilities classify under “at-rest” only + fail USFDA + WHO PIC/S inspections that test operational recovery.
- Solvent-handling exhaust missing — coating + drying with ethanol/IPA needs solvent-rated exhaust ducting (stainless or aluminium) + Class 1 Div 2 electrical + spark-resistant fans per NBC 2016 + IS/IEC 60079. Mild-steel ducts corrode + accumulate solvent residues that cause fires.
- HEPA integrity testing on wrong cadence — H13/H14 HEPAs need DOP/PAO challenge test at install + every 6 months (Grade A) or annually (Grade C/D). Single annual test is enough for ISO 14644 but Schedule M + USFDA both want 6-monthly for sterile areas.
- ISO 14644-1:2015 + 14644-2:2015 + 14644-3:2019 — Cleanrooms + Associated Controlled Environments.
- WHO Technical Report Series No. 1019 (2019) Annex 2 — WHO Good Manufacturing Practices for Sterile Pharmaceutical Products.
- Schedule M of Drugs + Cosmetics Rules 1945, revised 28 Dec 2023 (India), CDSCO.
- USFDA 21 CFR Part 211 + 2024 Guidance — cGMP for Finished Pharmaceuticals.
- EU GMP Annex 1:2022 — Manufacture of Sterile Medicinal Products.
- ISPE Baseline Guide Vol 3 Sterile Product Manufacturing Facilities 2018.
- ASHRAE Handbook HVAC Applications 2023 Ch 19 Clean Spaces.
- IEST RP-CC006.4 + RP-CC007.4 — Filter Testing.